Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Novo Nordisk Will Use Anthropic’s Claude for Drug Research (feeds.content.dowjones.io)
2.
Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism? (feeds.feedburner.com)
3.
Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude (feeds.content.dowjones.io)
4.
Novo Nordisk Breach Highlights Software Development Pipeline Risk (darkreading.com)
5.
Novo Nordisk Breach Exposes Software Development Pipeline Risk (darkreading.com)
6.
Leak confirms OpenAI is testing a ChatGPT for Science subscription (bleepingcomputer.com)
7.
Hacking Group Claims Major Hack of Novo Nordisk, Attempted $25 Million Extortion (slashdot.org)
8.
Pharma giant Novo Nordisk discloses breach of clinical trials data (bleepingcomputer.com)
9.
De novo design of quasisymmetric two-component protein cages (feeds.nature.com)
10.
Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic (gizmodo.com)
11.
Is the weight-loss drug boom moving past the Ozempic era? (feeds.feedburner.com)
12.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore (feeds.feedburner.com)
13.
The past, present and future of de novo protein design (feeds.nature.com)
14.
Best Gaming Chair for 2026 (cnet.com)
15.
How to secure philanthropic funding in a competitive climate (feeds.nature.com)
16.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery (feeds.content.dowjones.io)
17.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery (feeds.content.dowjones.io)
18.
Trump's Iran deadline, the Altman-Musk feud, Novo's Wegovy pill and more in Morning Squawk (cnbc.com)
19.
Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, and Other Glaring Red Flags? (futurism.com)
20.
Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, a Warning From the FDA, and Other Glaring Red Flags? (futurism.com)
21.
A new weight-loss pill is here, and it could reshape the GLP-1 market (feeds.feedburner.com)
22.
FDA Approves Eli Lilly's GLP-1 Pill (wired.com)
23.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone (feeds.feedburner.com)
24.
Ro CEO on the next phase of the Ozempic boom (feeds.feedburner.com)
25.
The Dow's losing streak, fertilizer prices, Novo Nordisk's new Wegovy shot and more in Morning Squawk (cnbc.com)
26.
Can weight-loss pills replace injectables? What the science says (feeds.nature.com)
27.
Novo Nordisk and Hims End Their Ozempic War. Here’s What It Means for You (gizmodo.com)
28.
Dow 50,000, Super Bowl 60, Meta's big week in court and more in Morning Squawk (cnbc.com)
29.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill (futurism.com)
30.
CNBC Daily Open: UBS posts strong earnings while Novo Nordisk's U.S. shares crater on slowing growth (cnbc.com)
Today's top topics: openai anthropic claude chatgpt android authority berkshire hathaway warren buffett artificial intelligence bug bounty ai safety
View all today's topics →